Details of the Drug Formulations

General Information of Drug (ID: DM32B5U)

Drug Name
Upadacitinib Drug Info
Synonyms ABT-494
Indication
Disease Entry ICD 11 Status REF
Rheumatoid arthritis FA20 Approved [1]
Psoriatic arthritis FA21 Phase 3 [2]
Atopic dermatitis EA80 Phase 2 [2]
Crohn disease DD70 Phase 2 [3]
Ulcerative colitis DD71 Phase 2 [3]
Cross-matching ID
PubChem CID
58557659
CAS Number
1310726-60-3
TTD ID
D07JAG
ACDINA ID
D01513

Full List of Drug Formulations Containing This Drug

Upadacitinib 15 mg Extended-Release tablet
Company Formulation ID FDA Description
Abbvie F23318 Microcrystalline Cellulose; Hypromellose; Mannitol; Tartaric Acid; Colloidal Silicon Dioxide; Magnesium Stearate; Polyvinyl Alcohol; Polyethylene Glycol; Talc; Titanium Dioxide; Ferrosoferric Oxide; Iron Oxide Red
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)